C. Frank Bennett, EVP, Chief Scientific Officer at IONIS PHARMACEUTICALS INC (IONS), sold 170,178 shares at $82.60 ($14.1M) on 2026-02-02, disclosed to the SEC on 2026-02-04.
Seasonal sale ($14.1M) by EVP, Chief Scientific Officer — this insider has traded IONS in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $82.60 | 20,000 | $1.7M | 11.7% |
| 2 | $82.60 | 20,000 | $1.7M | 11.7% |
| 3 | $83.03 | 16,463 | $1.4M | 9.7% |
| 4 | $83.03 | 48,626 | $4.0M | 28.6% |
| 5 | $83.03 | 16,463 | $1.4M | 9.7% |
| 6 | $83.03 | 48,626 |
| $4.0M |
| 28.6% |
| Total | $82.93 avg | 170,178 | $14.1M | 100% |
| Filing → |
| IONS | SELL | 2026-02-02 | $976K | — | Filing → |
| IONS | SELL | 2026-01-20 | $675K | — | Filing → |
| IONS | SELL | 2025-09-09 | $358K | — | Filing → |